Does ROSUVASTATIN Cause Corneal epithelium defect? 9 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Corneal epithelium defect have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.0% of all adverse event reports for ROSUVASTATIN.
9
Reports of Corneal epithelium defect with ROSUVASTATIN
0.0%
of all ROSUVASTATIN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Corneal epithelium defect From ROSUVASTATIN?
Of the 9 reports.
Is Corneal epithelium defect Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Corneal epithelium defect?
MOXIFLOXACIN (43)
PREDNISOLONE (37)
DEVICE (32)
BELANTAMAB MAFODOTIN (31)
RIBOFLAVIN 5'-PHOSPHATE (29)
DICLOFENAC (23)
METHOTREXATE (23)
PROPARACAINE (23)
BEVACIZUMAB (22)
CYCLOPENTOLATE (20)
Which ROSUVASTATIN Alternatives Have Lower Corneal epithelium defect Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN